Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, Punjab 143005, India.
Department of Pharmacy, Rayat-Bahara Group of Institutes, Hoshiarpur, 146001, Punjab, India.
Eur J Med Chem. 2016 Apr 13;112:298-346. doi: 10.1016/j.ejmech.2016.02.018. Epub 2016 Feb 11.
Kinases control a diverse set of cellular processes comprising of reversible phosphorylation of proteins. Protein kinases play a pivotal role in human tumor cell proliferation, migration and survival of neoplasia. In the recent past, purine based molecules have emerged as significantly potent kinase inhibitors. In view of their promising potential for the inhibition of kinases, this review article focuses on purines which have progressed as kinase inhibitors during the last five years. A detailed account of the design strategies employed for the synthesis of purine analogs exerting inhibitory effects on diverse kinases has been presented. Apart from presenting the design strategies, the article also highlights the structure activity relationship along with mechanistic insights revealed during the biological evaluation of the purine analogs for kinase inhibition. The interactions with the amino acid residues responsible for kinase inhibitory potential of purine based molecules have also been discussed. In this assemblage, purine based protein kinase inhibitors patented in the past have also been summarized in the tabular form. This compilation will be of great interest for the researchers working in the area of protein kinase inhibitors.
激酶控制着一系列多样化的细胞过程,包括蛋白质的可逆磷酸化。蛋白激酶在人类肿瘤细胞的增殖、迁移和肿瘤存活中起着关键作用。在最近的一段时间里,嘌呤类分子已成为非常有效的激酶抑制剂。鉴于它们在抑制激酶方面有很大的潜力,这篇综述文章集中讨论了在过去五年中作为激酶抑制剂发展起来的嘌呤类物质。本文详细介绍了用于合成对多种激酶具有抑制作用的嘌呤类似物的设计策略。除了提出设计策略外,本文还重点介绍了在嘌呤类似物的激酶抑制生物评估过程中揭示的构效关系和机制见解。还讨论了与负责嘌呤类分子激酶抑制潜力的氨基酸残基的相互作用。在这一部分中,过去获得专利的基于嘌呤的蛋白激酶抑制剂也以表格形式进行了总结。对于从事蛋白激酶抑制剂研究的研究人员来说,这一汇编将非常有趣。